Nathan Caffo

Insider Reports History

Location
Burlingame, CA
Signature
/s/ John Canepa, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nathan Caffo:

Company Role Class Num Shares Value Price $ Report Date Ownership
Candel Therapeutics, Inc. Chief Business Officer Common Stock 6,000 $5,400 $0.9000 29 Jul 2021 Direct

Insider Reports Filed by Nathan Caffo

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CADL Candel Therapeutics, Inc. 29 Jul 2021 1 +$48,000 4 Chief Business Officer 02 Aug 2021, 20:02
CADL Candel Therapeutics, Inc. 26 Jul 2021 0 $0 3 Chief Business Officer 26 Jul 2021, 21:18